Overview
Bancroftian filarial chylous ascites is a rare complication characterized by the accumulation of chyle in the peritoneal cavity, often resulting from lymphatic filarial infection leading to thoracic duct disruption 1.Diagnosis
Clinical Presentation: Recurrent abdominal distension, significant weight loss, and signs of malnutrition 1.
Imaging: Ultrasonography or CT scan may reveal ascites with characteristic fluid characteristics 1.
Fluid Analysis: High triglyceride content (4-40 gm/liter) in ascitic fluid confirms chylous nature 1.
Differential Diagnosis: Distinguish from other causes of ascites and pseudogout mimicking chylous effusions 1.Management
Antiparasitic Therapy: Diethylcarbamazine (DEC) is typically used, often in doses of 300 mg/day for several weeks 1.
Supportive Care: Nutritional support, fluid management, and treatment of complications 1.
Surgical Intervention: Rarely indicated for persistent cases or complications like bowel obstruction 1.Special Populations
No Specific Data: Abstracts do not provide specific guidance for pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Confirm diagnosis through ascitic fluid analysis showing high triglyceride content (Evidence: Moderate) 1.
Initiate treatment with diethylcarbamazine (DEC) at 300 mg/day for several weeks (Evidence: Expert opinion) 1.
Provide comprehensive supportive care including nutritional support and fluid management (Evidence: Expert opinion) 1.References
1 Adhikesavan LG, Ayoub WT, Schumacher HR. Misdiagnosis of a chylous cyst as chest wall gouty tophus: a case of true pseudogout. Arthritis and rheumatism 2007. link